Recruiting
Phase 2

Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)

Sponsor:

Cardurion Pharmaceuticals, Inc.

Code:

NCT06215586

Conditions

Heart Failure

Heart Failure Preserved Ejection Fraction

Cardiovascular Diseases

Heart Diseases

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tovinontrine (CRD-750

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information